The Effect of Adenorm on the Frequency of Expulsion of Proximal Ureter Calculi: an Open Randomized Controlled Study
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Conservative expulsive therapy with the use of alpha-blockers is effective for stones of the lower third of the ureter. Our study was conducted to assess the effectiveness of tamsulosin as part of the drug Adenorm for removing stones from the proximal ureter.
Materials and methods. An open, randomized controlled trial was conducted with 108 patients who agreed to the conservative treatment of a single radiopaque calculus of the upper third of the ureter with dimensions ≤6 mm. They were randomly assigned to group A (n=54, only general expulsive therapy) and group B (n=54, which received 0.4 mg of tamsulosin once a day). The primary measure of effectiveness was the frequency of the discharge of calculus (PSC) in the «population of patients with the intention to be treated» after 4 weeks of treatment. Secondary efficacy indicators were evaluated in the «population by protocol» and represented the time of the calculus, the indicator of the Euro-Quality-of-Life scale (EuroQOL – Euro Quality of Life) after the study, the need to take painkillers and the willingness to undergo conservative treatment again.
Results. The two groups were well balanced according to the initial characteristics of the patients and the calculus. Seventy-nine patients (73.1%; 35 from group A and 44 from group B) completed the study protocol. The total CHOK was 60.2% (65/108). Group B had a higher FER (74.1%; 40/54) than Group A (46.3%; 25/54; p=0.003) and a significantly shorter stone transit time (average days, A: 19, 6 vs. B: 14.3; p=0.005). The groups did not differ on the EuroQOL scale and on the need for anesthesia, while 74.3% (26/35) of Group A and 90.9% (40/44) of Group B were ready to undergo conservative treatment (p=0.048). Univariate logistic regression analysis showed that stone size (OR=1.474; p=0.045) and treatment with tamsulosin (OR=3.314; p=0.004) significantly influenced the stone’s discharge. In multivariate analysis, only tamsulosin was statistically significant (OR=3.198; p=0.021).
Findings. The use of tamsulosin as part of Adenorm was associated with a significantly better frequency of expulsion of stones and a shorter time of their passage, with primary single calculi of the upper third in sizes ≤ 6 mm compared with only conventional expulsive therapy. Our results show that, like patients with stones in the lower third of the ureter, conservative expulsive therapy using tamsulosin is a reasonable treatment option for patients and with calculi of the proximal third of the ureter.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Preminger GM, Tiselius HG, Assimos DG et al. 2007 guideline for the management of ureteral calculi. J Urol 2007;178:2418–34. https://doi.org/10.1016/j.juro.2007.09.107
Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 2003;170:2202–5. https://doi.org/10.1097/01.ju.0000096050.22281.a7
De Sio M, Autorino R, Di Lorenzo G et al. Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience. J Endourol 2006;20:12–6. https://doi.org/10.1089/end.2006.20.12
Yilmaz E, Batislam E, Basar MM et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 2005;173:2010–2. https://doi.org/10.1097/01.ju.0000158453.60029.0a
Seitz C, Liatsikos E, Porpiglia F et al. Medical therapy to facilitate the passage of stones: what is theevidence? Eur Urol 2009;56:455–71. https://doi.org/10.1016/j.eururo.2009.06.012
Hollingsworth JM, Rogers MA, Kaufman SR et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006;368:1171–9. https://doi.org/10.1016/S0140-6736(06)69474-9
Morita T, Ando M, Kihara K, Oshima H. Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol Urodyn 1994;13:315–21. http://dx.doi.org/10.1002/1520-6777(1994)13:33.0.CO;2-G
Hieble JP, Bylund DB, Clarke DE et al. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors:consensus update. Pharmacol Rev 1995;47:267–70. PDF
Sigala S, Dellabella M, Milanese G et al. Evidence for the presence of alpha 1-adrenoceptor subtypesin the human ureter. Neurourol Urodyn 2005;24:142–8. https://doi.org/10.1002/nau.20097
Itoh Y, Kojima Y, Yasui T et al. Examination of alpha 1-adrenoceptor subtypes in the human ureter. Int J Urol 2007;14:749–53. https://doi.org/10.1111/j.1442-2042.2007.01812.x
Park HK, Choi EY, Jeong BC et al. Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. Urol Res 2007;35:325–9. https://doi.org/10.1007/s00240-007-0118-0
Park J, Hong B, Park T, Park HK. Effectiveness of non-contrast computed tomography in evaluation of residual stones after percutaneous nephrolithotomy. J Endourol 2007;21:684–7. https://doi.org/10.1089/end.2006.0352
Lee WJ, Song KH, Noh JH et al. Health-related quality of life using the EuroQol 5D questionnaire in Korean patients with type 2 diabetes. J Korean Med Sci 2012;27:255–60. https://doi.org/10.3346/jkms.2012.27.3.255
Cooper JT, Stack GM, Cooper TP. Intensive medical management of ureteral calculi. Urology 2000;56:575–8. http://dx.doi.org/10.1016/S0090-4295(00)00658-0
Park J, Shin DW, Chung JH, Lee SW. Shock wave lithotripsy versus ureteroscopy for ureteral calculi: a prospective assessment of patient-reported outcomes. World J Urol 2013;31(6):1569–74. https://doi.org/10.1007/s00345-012-0966-2
Park J, Shin DW, You C et al. Crosscultural application of the Korean version of Ureteral Stent Symptoms Questionnaire. J Endourol 2012;26:1518–22. https://doi.org/10.1089/end.2012.0235
Porpiglia F, Ghignone G, Fiori C et al. Nifedipine versus tamsulosin for the management of lowerureteral stones. J Urol 2004;172:568–71. https://doi.org/10.1097/01.ju.0000132390.61756.ff
Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 1999;162:688–90;discussion 690–1. https://doi.org/10.1097/00005392-199909010-00014
Yencilek F, Erturhan S, Canguven O et al. Does tamsulosin change the management of proximally-located ureteral stones? Urol Res 2010;38:195–9. https://doi.org/10.1007/s00240-010-0257-6
Hanna MK JR, Sturgess JM, Barkin M. Ureteral structure and ultrastructure. Part I. The normal human ureter. J Urol 1976;116:718–24. https://doi.org/10.1016/S0022-5347(17)58986-7
Richardson CD, Donatucci CF, Page SO et al. Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. Prostate 1997;33:55–9. https://doi.org/10.1002/(SICI)1097-0045(19970915)33:1%3C55::AID-PROS9%3E3.0.CO;2-8
Kojima Y, Sasaki S, Kubota Y et al. Up-regulation of alpha1a- and alpha1d-adrenoceptors in the prostate by administration of subtype selective alpha1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia. J Urol 2011;186:1530–6. https://doi.org/10.1016/j.juro.2011.05.048
Bensalah K, Pearle M, Lotan Y. Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 2008;53:411–8. https://doi.org/10.1016/j.eururo.2007.09.012
Lotan Y, Gettman MT, Roehrborn CG et al. Management of ureteral calculi: a cost comparison and decision-making analysis. J Urol 2002;167:621–9. https://doi.org/10.1016/S0022-5347(05)65166-X
